Koukourakis, M I <br/><br/>
High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.  [electronic resource] 

 -  Anticancer research   
 - 2973-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amifostine--administration & dosage<br/>Arm--pathology<br/>Brachial Plexus--radiation effects<br/>Breast--pathology<br/>Breast Neoplasms--mortality<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Edema--etiology<br/>Feasibility Studies<br/>Female<br/>Fibrosis<br/>Humans<br/>Hypotension--chemically induced<br/>Middle Aged<br/>Peripheral Nervous System Diseases--etiology<br/>Pulmonary Fibrosis--etiology<br/>Radiation Injuries--epidemiology<br/>Radiation Pneumonitis--etiology<br/>Radiation-Protective Agents--administration & dosage<br/>Radiodermatitis--etiology<br/>Radiotherapy, High-Energy--adverse effects<br/>Severity of Illness Index<br/>Survival Analysis<br/>Treatment Outcome<br/>Vomiting--chemically induced